Smith & Howard Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-952
Closed -$232K 69
2021
Q2
$232K Sell
952
-70
-7% -$17.2K 0.11% 59
2021
Q1
$254K Hold
1,022
0.13% 51
2020
Q4
$235K Hold
1,022
0.13% 57
2020
Q3
$260K Sell
1,022
-9
-0.9% -$2.23K 0.15% 53
2020
Q2
$243K Sell
1,031
-47
-4% -$10.7K 0.15% 57
2020
Q1
$219K Sell
1,078
-90
-8% -$19.7K 0.14% 58
2019
Q4
$282K Buy
+1,168
New +$257K 0.1% 65
2014
Q1
Sell
-300
Closed -$34K 50
2013
Q4
$34K Buy
300
+100
+50% +$11.4K 0.02% 127
2013
Q3
$22K Sell
200
-905
-82% -$98.1K 0.01% 149
2013
Q2
$109K Buy
+1,105
New +$115K 0.07% 56

Other funds holding AMGN

Smith & Howard Wealth Management's AMGN Position: Q3 2021 in Review

Smith & Howard Wealth Management sold out of Amgen (AMGN) in Q3 2021, closing a stake of 952 shares — an estimated $232K sold.

Smith & Howard Wealth Management first reported a position in AMGN in Q2 2013 and held it in 10 quarters. The position peaked at $282K in Q4 2019. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.

  • Smith & Howard Wealth Management reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
  • Smith & Howard Wealth Management sold 952 Amgen shares in Q3 2021, an estimated $232K.
  • Smith & Howard Wealth Management first reported a position in Amgen in Q2 2013 and held it in 10 quarters.
  • Smith & Howard Wealth Management's Amgen position peaked at $282K in Q4 2019.
  • 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.

Based on Smith & Howard Wealth Management's 13F filing for Q3 2021, filed 22 Oct 2021.